In the realm of cancer therapy, the pursuit of innovative and effective treatments has been relentless. Over the years, immunotherapy has emerged as a promising avenue, with the potential to revolutionize the way we combat cancer. Among the various immunotherapeutic approaches, gamma-delta (γδ) T cell therapy has garnered significant attention due to its remarkable potential to target and eliminate cancer cells. Recent breakthroughs in the manufacturing of γδ T cell therapy, as presented by IN8bio at the ASGCT 2024, now offer renewed hope for patients and clinicians alike.
A Groundbreaking Milestone
The oral presentation by IN8bio
Comments